NOVO NORDISK A/S-B (NOV.DE) Fundamental Analysis & Valuation

Q: What is the fundamental rating for NOV stock?

ChartMill assigns a fundamental rating of 6 / 10 to NOV.DE.

Q: How profitable is NOVO NORDISK A/S-B (NOV.DE) stock?

NOVO NORDISK A/S-B (NOV.DE) has a profitability rating of 9 / 10.

Q: Can you provide the dividend sustainability for NOV stock?

The dividend rating of NOVO NORDISK A/S-B (NOV.DE) is 7 / 10 and the dividend payout ratio is 50.53%.

FRA:NOV • DK0062498333

37.265 EUR

+1.05 (+2.91%)

Last: May 4, 2026, 10:29 AM

This NOV.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1. NOV.DE Profitability Analysis

1.1 Basic Checks

NOV had positive earnings in the past year.
In the past year NOV had a positive cash flow from operations.
In the past 5 years NOV has always been profitable.
In the past 5 years NOV always reported a positive cash flow from operatings.

1.2 Ratios

NOV has a Return On Assets of 18.87%. This is amongst the best in the industry. NOV outperforms 93.88% of its industry peers.
NOV's Return On Equity of 52.79% is amongst the best of the industry. NOV outperforms 91.84% of its industry peers.
NOV has a better Return On Invested Capital (30.79%) than 95.92% of its industry peers.
NOV had an Average Return On Invested Capital over the past 3 years of 43.61%. This is significantly above the industry average of 13.96%.
The 3 year average ROIC (43.61%) for NOV is well above the current ROIC(30.79%). The reason for the recent decline needs to be investigated.

		Industry Rank	Sector Rank
ROA	18.87%
ROE	52.79%
ROIC	30.79%

ROA(3y)22.39%

ROA(5y)22.95%

ROE(3y)67.23%

ROE(5y)67.14%

ROIC(3y)43.61%

ROIC(5y)44.74%

1.3 Margins

NOV has a Profit Margin of 33.14%. This is amongst the best in the industry. NOV outperforms 95.92% of its industry peers.
NOV's Profit Margin has been stable in the last couple of years.
NOV has a Operating Margin of 41.30%. This is amongst the best in the industry. NOV outperforms 93.88% of its industry peers.
NOV's Operating Margin has been stable in the last couple of years.
NOV has a better Gross Margin (80.98%) than 85.71% of its industry peers.
In the last couple of years the Gross Margin of NOV has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	41.3%
PM (TTM)	33.14%
GM	80.98%

OM growth 3Y-1.15%

OM growth 5Y-0.81%

PM growth 3Y1.84%

PM growth 5Y-0.03%

GM growth 3Y-1.18%

GM growth 5Y-0.61%

More info and screens

ROA ROE ROIC Operating and Profit Margin Show most profitable peers

2. NOV.DE Health Analysis

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NOV is creating value.
The number of shares outstanding for NOV remains at a similar level compared to 1 year ago.
Compared to 5 years ago, NOV has more shares outstanding
NOV has a worse debt/assets ratio than last year.

2.2 Solvency

NOV has an Altman-Z score of 3.33. This indicates that NOV is financially healthy and has little risk of bankruptcy at the moment.
NOV has a Altman-Z score (3.33) which is in line with its industry peers.
NOV has a debt to FCF ratio of 4.52. This is a neutral value as NOV would need 4.52 years to pay back of all of its debts.
The Debt to FCF ratio of NOV (4.52) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.61 indicates that NOV is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.61, NOV perfoms like the industry average, outperforming 48.98% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.61
Debt/FCF	4.52
Altman-Z	3.33

ROIC/WACC4.86

WACC6.33%

2.3 Liquidity

NOV has a Current Ratio of 0.80. This is a bad value and indicates that NOV is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.80, NOV is doing worse than 81.63% of the companies in the same industry.
NOV has a Quick Ratio of 0.80. This is a bad value and indicates that NOV is not financially healthy enough and could expect problems in meeting its short term obligations.
NOV has a worse Quick ratio (0.57) than 83.67% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.8
Quick Ratio	0.57

More info and screens

WACC Debt/Equity How to determine the health of a company Altman-Z score Show peers with great health

3. NOV.DE Growth Analysis

3.1 Past

NOV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.77%.
The Earnings Per Share has been growing by 20.66% on average over the past years. This is a very strong growth
NOV shows a small growth in Revenue. In the last year, the Revenue has grown by 6.43%.
The Revenue has been growing by 19.48% on average over the past years. This is quite good.

EPS 1Y (TTM)1.77%

EPS 3Y23.52%

EPS 5Y20.66%

EPS Q2Q%-4.73%

Revenue 1Y (TTM)6.43%

Revenue growth 3Y20.43%

Revenue growth 5Y19.48%

Sales Q2Q%-7.63%

3.2 Future

The Earnings Per Share is expected to grow by 3.93% on average over the next years.
Based on estimates for the next years, NOV will show a small growth in Revenue. The Revenue will grow by 3.35% on average per year.

EPS Next Y-7.2%

EPS Next 2Y-3.65%

EPS Next 3Y0.38%

EPS Next 5Y3.93%

Revenue Next Year-6.27%

Revenue Next 2Y-1.41%

Revenue Next 3Y1.06%

Revenue Next 5Y3.35%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks Show best growing peers

4. NOV.DE Valuation Analysis

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.10, the valuation of NOV can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of NOV indicates a rather cheap valuation: NOV is cheaper than 81.63% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.51. NOV is valued rather cheaply when compared to this.
NOV is valuated correctly with a Price/Forward Earnings ratio of 13.03.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NOV indicates a somewhat cheap valuation: NOV is cheaper than 77.55% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.41, NOV is valued a bit cheaper.

		Industry Rank	Sector Rank
PE	12.1
Fwd PE	13.03

4.2 Price Multiples

NOV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NOV is cheaper than 87.76% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, NOV is valued a bit more expensive than 63.27% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	32.56
EV/EBITDA	6.82

4.3 Compensation for Growth

NOV has an outstanding profitability rating, which may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)0.59

EPS Next 2Y-3.65%

EPS Next 3Y0.38%

More info and screens

Price/Earnings Price/FCF FCF per share EV/EBITDA PEG RATIO Show best valued peers

5. NOV.DE Dividend Analysis

5.1 Amount

NOV has a Yearly Dividend Yield of 4.30%, which is a nice return.
In the last 3 months the price of NOV has falen by -27.19%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 1.83, NOV pays a better dividend. On top of this NOV pays more dividend than 85.71% of the companies listed in the same industry.
NOV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.

		Industry Rank	Sector Rank
Dividend Yield	4.3%

5.2 History

The dividend of NOV is nicely growing with an annual growth rate of 19.05%!

Dividend Growth(5Y)19.05%

Div Incr Years1

Div Non Decr Years1

5.3 Sustainability

50.53% of the earnings are spent on dividend by NOV. This is a bit on the high side, but may be sustainable.
The dividend of NOV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

DP50.53%

EPS Next 2Y-3.65%

EPS Next 3Y0.38%

More info and screens

Find the best dividend stocks Show peers with best dividend

NOV.DE Fundamentals: All Metrics, Ratios and Statistics

NOVO NORDISK A/S-B

FRA:NOV (5/4/2026, 10:29:12 AM)

37.265

+1.05 (+2.91%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Industry StrengthN/A

Industry GrowthN/A

Earnings (Last)02-03 2026-02-03/amc

Earnings (Next)05-06 2026-05-06/bmo

Inst Owners31.87%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap126.33B

Revenue(TTM)309.06B

Net Income(TTM)102.43B

Analysts67.57

Price Target43.11 (15.68%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	4.3%

Yearly Dividend1.56

Dividend Growth(5Y)19.05%

DP50.53%

Div Incr Years1

Div Non Decr Years1

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-2.82%

Min EPS beat(2)-7.04%

Max EPS beat(2)1.39%

EPS beat(4)2

Avg EPS beat(4)-0.71%

Min EPS beat(4)-7.04%

Max EPS beat(4)3.94%

EPS beat(8)5

Avg EPS beat(8)1.01%

EPS beat(12)8

Avg EPS beat(12)1.47%

EPS beat(16)11

Avg EPS beat(16)1.68%

Revenue beat(2)1

Avg Revenue beat(2)-1.06%

Min Revenue beat(2)-3.19%

Max Revenue beat(2)1.07%

Revenue beat(4)1

Avg Revenue beat(4)-0.92%

Min Revenue beat(4)-3.19%

Max Revenue beat(4)1.07%

Revenue beat(8)3

Avg Revenue beat(8)0.15%

Revenue beat(12)6

Avg Revenue beat(12)0.52%

Revenue beat(16)9

Avg Revenue beat(16)0.84%

PT rev (1m)-12.7%

PT rev (3m)-19.26%

EPS NQ rev (1m)8.46%

EPS NQ rev (3m)15.44%

EPS NY rev (1m)-3.37%

EPS NY rev (3m)-6.18%

Revenue NQ rev (1m)-2.12%

Revenue NQ rev (3m)-37.39%

Revenue NY rev (1m)0.03%

Revenue NY rev (3m)-6.51%

Valuation

		Industry Rank	Sector Rank
PE	12.1
Fwd PE	13.03
P/S	3.05
P/FCF	32.56
P/OCF	7.93
P/B	4.86
P/tB	14.75
EV/EBITDA	6.82

EPS(TTM)3.08

EY8.27%

EPS(NY)2.86

Fwd EY7.68%

FCF(TTM)1.14

FCFY3.07%

OCF(TTM)4.7

OCFY12.62%

SpS12.2

BVpS7.66

TBVpS2.53

PEG (NY)N/A

PEG (5Y)0.59

Graham Number23.0412 (-38.17%)

Profitability

		Industry Rank	Sector Rank
ROA	18.87%
ROE	52.79%
ROCE	39.01%
ROIC	30.79%
ROICexc	33.56%
ROICexgc	59.2%
OM	41.3%
PM (TTM)	33.14%
GM	80.98%
FCFM	9.38%

ROA(3y)22.39%

ROA(5y)22.95%

ROE(3y)67.23%

ROE(5y)67.14%

ROIC(3y)43.61%

ROIC(5y)44.74%

ROICexc(3y)50.94%

ROICexc(5y)53.03%

ROICexgc(3y)100.46%

ROICexgc(5y)105.49%

ROCE(3y)55.75%

ROCE(5y)58.53%

ROICexgc growth 3Y-22.89%

ROICexgc growth 5Y-7.78%

ROICexc growth 3Y-18.13%

ROICexc growth 5Y-11.63%

OM growth 3Y-1.15%

OM growth 5Y-0.81%

PM growth 3Y1.84%

PM growth 5Y-0.03%

GM growth 3Y-1.18%

GM growth 5Y-0.61%

F-Score5

Asset Turnover0.57

Health

		Industry Rank	Sector Rank
Debt/Equity	0.61
Debt/FCF	4.52
Debt/EBITDA	0.79
Cap/Depr	409.94%
Cap/Sales	29.16%
Interest Coverage	37.34
Cash Conversion	79.59%
Profit Quality	28.3%
Current Ratio	0.8
Quick Ratio	0.57
Altman-Z	3.33

F-Score5

WACC6.33%

ROIC/WACC4.86

Cap/Depr(3y)363.9%

Cap/Depr(5y)282.93%

Cap/Sales(3y)21.19%

Cap/Sales(5y)15.43%

Profit Quality(3y)60.31%

Profit Quality(5y)79.23%

High Growth Momentum

Growth

EPS 1Y (TTM)1.77%

EPS 3Y23.52%

EPS 5Y20.66%

EPS Q2Q%-4.73%

EPS Next Y-7.2%

EPS Next 2Y-3.65%

EPS Next 3Y0.38%

EPS Next 5Y3.93%

Revenue 1Y (TTM)6.43%

Revenue growth 3Y20.43%

Revenue growth 5Y19.48%

Sales Q2Q%-7.63%

Revenue Next Year-6.27%

Revenue Next 2Y-1.41%

Revenue Next 3Y1.06%

Revenue Next 5Y3.35%

EBIT growth 1Y-4.76%

EBIT growth 3Y19.04%

EBIT growth 5Y18.51%

EBIT Next Year8.72%

EBIT Next 3Y6.24%

EBIT Next 5Y8.11%

FCF growth 1Y-58.38%

FCF growth 3Y-23.26%

FCF growth 5Y-0.6%

OCF growth 1Y-1.54%

OCF growth 3Y14.72%

OCF growth 5Y18.05%

NOVO NORDISK A/S-B / NOV.DE Fundamental Analysis FAQ

What is the fundamental rating for NOV stock?

ChartMill assigns a fundamental rating of 6 / 10 to NOV.DE.

Can you provide the valuation status for NOVO NORDISK A/S-B?

ChartMill assigns a valuation rating of 5 / 10 to NOVO NORDISK A/S-B (NOV.DE). This can be considered as Fairly Valued.

How profitable is NOVO NORDISK A/S-B (NOV.DE) stock?

NOVO NORDISK A/S-B (NOV.DE) has a profitability rating of 9 / 10.

What is the financial health of NOVO NORDISK A/S-B (NOV.DE) stock?

The financial health rating of NOVO NORDISK A/S-B (NOV.DE) is 3 / 10.

Can you provide the dividend sustainability for NOV stock?

The dividend rating of NOVO NORDISK A/S-B (NOV.DE) is 7 / 10 and the dividend payout ratio is 50.53%.